About Genprex (GNPX)
Genprex, Inc. is a clinical-stage gene therapy company. The Company is focused on the development of gene-based therapies for patients with unmet medical needs. The Company's lead oncology drug candidate, REQORSA Immunogen therapy drug (quaratusugene... Read more
- USD0.24
- USD0.24
- USD0.23
- USD4.09
- -35.00%
- --
- 84.87k
- 7.43M
- 6M
- 0.22
- -89.90%
Stock News
yesterday
Whirlpool says it’s a ‘winner’ under new tariffs, as consumers stay cautious
MarketWatch
yesterday
GE Vernova CEO says current U.S. demand for electricity is the largest since the end of WWII
CNBC
yesterday
Alaska Airlines warns of slower demand as second-quarter profit outlook falls short
CNBC
yesterday
Brookline: Q1 Earnings Snapshot
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
